PDA

View Full Version : Combination therapy shows promise against HER2-positive metastatic breast cancer


News
07-10-2011, 11:50 PM
Adding Afinitor to Herceptin, the main treatment for HER2-positive metastatic breast cancer, helps some women with disease that has been resistant to previous Herceptin-based therapies, according to a study led by researchers at The University of Texas MD Anderson Cancer Center and published in the Journal of Clinical Oncology.

More... (http://www.news-medical.net/news/20110711/Combination-therapy-shows-promise-against-HER2-positive-metastatic-breast-cancer.aspx)

Jackie07
07-11-2011, 05:46 AM
"... offers a 'chemotherapy-free' option..." - sounds good!